Onconetix says Realbotix acquisition closing expected in H2 2026

Onconetix Inc

Onconetix Inc

ONCO

0.00
  • Onconetix has a definitive share exchange agreement to acquire 100% of Realbotix LLC in an all-stock deal.
  • Realbotix LLC is a wholly owned subsidiary of Realbotix Corp., which develops AI-powered humanoid robots for enterprise and consumer use.
  • Closing is expected in the second half of 2026, subject to shareholder and regulatory approvals and other closing conditions.
  • The combined company is expected to trade on Nasdaq following completion of the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606240830PRIMZONEFULLFEED9751625) on June 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.